New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 1, 2014
11:59 EDTNVDQ, ISRG, SYKIntuitive Surgical climbs after new surgical system debuts
Shares of surgical instrument and accessory maker Intuitive Surgical (ISRG) are climbing after the company announced the FDA cleared the U.S introduction of its new da Vinci Xi Surgical System. WHAT'S NEW: Intuitive Surgical introduced the da Vinci Xi Surgical System, which it says has broader capabilities than prior generations of its prior generation da Vinci System. Intuitive said it designed the new da Vinci Xi System with the goal of further advancing the technology used in minimally invasive surgery for complex diseases and conditions in gynecology, urology, thoracic, cardiac, and general surgery. ANALYST OPINON: Research firm Leerink sees today's news as a positive for Intuitive Surgical, but said it is uncertain exactly how many incremental system sales the da Vinci XI Surgical system will fuel and whether the features of Intuitive's new robot will lead to increased utilization into new surgery areas. The firm keeps the stock at a Market Perform rating. JPMorgan responded to the news by raising its price target on Intuitive Surgical to $500 from $475. JPMorgan said it views the new system as a significant positive that has the potential to both drive a replacement cycle and further increase penetration and utilization of the company's products within hospitals. PRICE ACTION: Near midday, shares of Intuitive Surgical were up about $39, or 8.9%, to $477. OTHERS TO WATCH: Novadaq (NVDQ), which sells consoles for Intuitive Surgical's robotic systems, rose 2.2% to $22.77. Shares of Stryker (SYK), which previously acquired robotic surgery systems maker MAKO Surgical, were little changed near noon.
News For ISRG;NVDQ;SYK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 3, 2015
09:57 EDTSYKSmith & Nephew drops after Stryker announces buyback plan
Shares of Smith & Nephew (SNN) are moving lower after Stryker (SYK) announced this morning that its board approved a new $2B share repurchase program. "We remain committed to pursuing a capital allocation strategy that includes acquisitions, dividends and share repurchases," said Stryker CEO Kevin Lobo. He added, "While M&A activity across the breadth of our product and service offerings will remain the primary focus of our long-term growth strategy, this new authorization recognizes that the strength of our balance sheet is sufficient to enable more significant share repurchases." The news has Smith & Nephew, viewed as a potential takeover target for Stryker, trading off 5% in early trading to $34.96.
08:38 EDTSYKStryker announces new $2B share repurchase authorization
Subscribe for More Information
08:25 EDTISRGIntuitive Surgical defense award an incremental positive, says Leerink
Subscribe for More Information
March 2, 2015
18:52 EDTISRGOn The Fly: After Hours Movers
Subscribe for More Information
17:19 EDTISRGIntuitive Surgical awarded $430M government contract
Subscribe for More Information
10:53 EDTNVDQNovadaq assumed with an Overweight at Piper Jaffray
Subscribe for More Information
February 27, 2015
12:50 EDTSYKSmith & Nephew, Stryker seen as potential headliners of 2015 M&A, TheDeal says
Subscribe for More Information
February 25, 2015
16:19 EDTNVDQNovadaq sees 2015 revenue $65M, consensus $69.24M
16:19 EDTNVDQNovadaq reports Q4 EPS ex-items (10c), consensus (9c)
Reports Q4 revenue $13M, consensus $13.87M.
February 20, 2015
08:27 EDTSYKStryker has a conference call hosted by JPMorgan
Subscribe for More Information
07:09 EDTNVDQBTIG to hold a conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use